3.17
price down icon1.86%   -0.06
after-market Dopo l'orario di chiusura: 3.15 -0.02 -0.63%
loading
Precedente Chiudi:
$3.23
Aprire:
$3.25
Volume 24 ore:
140.48K
Relative Volume:
0.49
Capitalizzazione di mercato:
$122.30M
Reddito:
-
Utile/perdita netta:
$-42.05M
Rapporto P/E:
-1.1241
EPS:
-2.82
Flusso di cassa netto:
$-35.26M
1 W Prestazione:
+0.96%
1M Prestazione:
+0.32%
6M Prestazione:
-5.65%
1 anno Prestazione:
+64.25%
Intervallo 1D:
Value
$3.15
$3.2898
Intervallo di 1 settimana:
Value
$3.075
$3.30
Portata 52W:
Value
$1.595
$10.48

Protara Therapeutics Inc Stock (TARA) Company Profile

Name
Nome
Protara Therapeutics Inc
Name
Telefono
646-844-0337
Name
Indirizzo
345 PARK AVENUE SOUTH, NEW YORK, NY
Name
Dipendente
33
Name
Cinguettio
Name
Prossima data di guadagno
2025-03-05
Name
Ultimi documenti SEC
Name
TARA's Discussions on Twitter

Confronta TARA con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
TARA
Protara Therapeutics Inc
3.17 122.30M 0 -42.05M -35.26M -2.82
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
396.93 102.81B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
453.54 58.59B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
567.22 61.25B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
733.66 43.23B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
318.73 36.53B 3.81B -644.79M -669.77M -6.24

Protara Therapeutics Inc Stock (TARA) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-04-16 Iniziato Scotiabank Sector Outperform
2025-03-14 Iniziato Cantor Fitzgerald Overweight
2023-07-10 Ripresa Guggenheim Buy
2021-06-04 Iniziato H.C. Wainwright Buy
2021-02-17 Iniziato Oppenheimer Outperform
2020-10-19 Iniziato Cowen Outperform
2020-07-29 Iniziato Guggenheim Buy
Mostra tutto

Protara Therapeutics Inc Borsa (TARA) Ultime notizie

pulisher
Sep 03, 2025

Should you hold or exit Protara Therapeutics Inc. nowJuly 2025 Gainers & Low Drawdown Momentum Trade Ideas - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Protara Therapeutics shares rise 3.79% intraday after announcing inducement grants to new employees. - AInvest

Sep 03, 2025
pulisher
Sep 03, 2025

Technical signs of recovery in Protara Therapeutics Inc.Weekly Stock Report & Consistent Return Investment Signals - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Published on: 2025-09-03 04:42:20 - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

How to escape a deep drawdown in Protara Therapeutics Inc.GDP Growth & Technical Entry and Exit Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Full technical analysis of Protara Therapeutics Inc. stock2025 Top Decliners & Expert Approved Trade Ideas - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

What institutional flow reveals about Protara Therapeutics Inc.Share Buyback & Stock Portfolio Risk Management - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Candlestick signals on Protara Therapeutics Inc. stock today2025 Market Sentiment & Reliable Price Action Trade Plans - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

What Fibonacci levels say about Protara Therapeutics Inc. reboundRisk Management & Real-Time Chart Breakout Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Published on: 2025-09-03 00:07:37 - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Market reaction to Protara Therapeutics Inc.’s recent newsWeekly Trading Summary & Fast Gaining Stock Reports - Newser

Sep 03, 2025
pulisher
Sep 02, 2025

Published on: 2025-09-02 22:40:30 - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Can momentum traders help lift Protara Therapeutics Inc.2025 Trading Recap & Reliable Breakout Stock Forecasts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Aug Catalysts: What is Protara Therapeutics Inc.’s TAM (Total Addressable Market)July 2025 Decliners & AI Forecast Swing Trade Picks - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Protara Therapeutics’ Equity Inducement Grants: A Strategic Catalyst for Talent Retention and Long-Term Value Creation - AInvest

Sep 02, 2025
pulisher
Sep 02, 2025

Protara Therapeutics shares fall 1.89% after-hours following inducement grants to new employees. - AInvest

Sep 02, 2025
pulisher
Sep 02, 2025

Protara Therapeutics, Inc. reports inducement grants under Nasdaq Listing Rule 5635(c)(4) - MarketScreener

Sep 02, 2025
pulisher
Sep 02, 2025

Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Sep 02, 2025
pulisher
Sep 02, 2025

Biotech Firm Protara Therapeutics Issues $3.17/Share Stock Options in Key Employee Compensation Plan - Stock Titan

Sep 02, 2025
pulisher
Sep 02, 2025

Published on: 2025-09-02 12:19:22 - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Protara Therapeutics Inc.’s volatility index tracking explainedPortfolio Return Report & AI Powered Trade Plan Recommendations - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

What data driven models say about Protara Therapeutics Inc.’s futureBond Market & AI Forecasted Entry and Exit Points - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Is Protara Therapeutics Inc. vulnerable to short sellers2025 Trading Volume Trends & Intraday High Probability Setup Alerts - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

What is the earnings history of Protara Therapeutics Inc.2025 Performance Recap & Smart Investment Allocation Tips - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Published on: 2025-09-02 08:13:43 - khodrobank.com

Sep 02, 2025
pulisher
Sep 01, 2025

Is Protara Therapeutics Inc. a top pick in the sectorJuly 2025 Rallies & Expert Approved Momentum Ideas - khodrobank.com

Sep 01, 2025
pulisher
Sep 01, 2025

Chartists Watching For Breakout in Protara Therapeutics Inc. getLinesFromResByArray error: size == 0 - thegnnews.com

Sep 01, 2025
pulisher
Sep 01, 2025

How to use a screener to detect Protara Therapeutics Inc. breakoutsMarket Activity Recap & Real-Time Volume Analysis - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Using economic indicators to assess Protara Therapeutics Inc. potential2025 Winners & Losers & Weekly Consistent Profit Watchlists - Newser

Sep 01, 2025
pulisher
Aug 31, 2025

How to build a dashboard for Protara Therapeutics Inc. stockJuly 2025 Earnings & Low Risk Entry Point Guides - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Is now a turning point for Protara Therapeutics Inc.Weekly Gains Summary & Long-Term Capital Growth Ideas - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Detecting support and resistance levels for Protara Therapeutics Inc.2025 Top Gainers & Free High Return Stock Watch Alerts - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

MACD Signals Flash Warning for Protara Therapeutics Inc. Stock getLinesFromResByArray error: size == 0 - kangso.co.kr

Aug 31, 2025
pulisher
Aug 31, 2025

Combining machine learning predictions for Protara Therapeutics Inc.July 2025 Market Mood & Target Return Focused Picks - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

How to track smart money flows in Protara Therapeutics Inc.Weekly Trade Recap & Scalable Portfolio Growth Methods - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

What’s the recovery path for long term holders of Protara Therapeutics Inc.July 2025 Summary & Free Safe Entry Trade Signal Reports - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Using data filters to optimize entry into Protara Therapeutics Inc.Price Action & Daily Oversold Stock Bounce Ideas - Newser

Aug 31, 2025
pulisher
Aug 30, 2025

Published on: 2025-08-30 16:26:05 - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Backtesting results for Protara Therapeutics Inc. trading strategiesEarnings Growth Report & Safe Capital Growth Plans - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Can volume confirm reversal in Protara Therapeutics Inc.July 2025 Volume & Expert Approved Momentum Ideas - Newser

Aug 30, 2025

Protara Therapeutics Inc Azioni (TARA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Protara Therapeutics Inc Azioni (TARA) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Zummo Jacqueline
Chf Scientific Operations Off
Mar 26 '25
Sale
4.53
21,224
96,145
98,861
$85.44
price down icon 1.75%
$27.38
price up icon 1.11%
$23.80
price up icon 1.19%
$103.50
price up icon 3.07%
$142.53
price down icon 0.68%
biotechnology ONC
$318.73
price down icon 5.21%
Capitalizzazione:     |  Volume (24 ore):